Modulation of interferon signaling by hepatitis C virus non-structural 5A protein: Implication of genotypic difference in interferon treatment

被引:7
|
作者
Kang, Sang-Min [1 ]
Won, Seung-Jae [1 ]
Lee, Gun-Hee [1 ]
Lim, Yun-Sook [1 ]
Hwang, Soon B. [1 ]
机构
[1] Hallym Univ, Natl Res Lab Hepatitis C Virus, Ilsong Inst Life Sci, Anyang 431060, South Korea
关键词
Hepatitis C virus; NS5A protein; Interferon signaling; Differential interferon antagonism; NECROSIS-FACTOR-ALPHA; KAPPA-B; EXPRESSION; PATHWAY; INTERLEUKIN-8; KINASE; INHIBITION; INDUCTION; TRANSDUCTION; ACTIVATION;
D O I
10.1016/j.febslet.2010.08.032
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interferon (IFN) response rate in hepatitis C virus (HCV) patients has been varied with genotypes. In this study, we investigated the effects of HCV NS5A protein on IFN resistance and compared the genotypic differences of NS5A. We showed that IFN-alpha-, poly I:C-, and Sendai virus-induced ISRE transcriptional activities were inhibited by both genotype 1b and 2a NS5A protein. We demonstrated that not only genotype 1b but also genotype 2a NS5A exerted the similar extent of IFN-alpha-induced antiviral activity. We showed that NS5A derived from both genotype 1b and 2a showed no significant differential IFN responses as seen in HCV patients. These data imply that some other host factor may be involved in genotypic differences of IFN antagonism in HCV patients. (c) 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:4069 / 4076
页数:8
相关论文
共 50 条
  • [21] Relationship between the effect of interferon therapy and the change of hepatitis C virus non-structural 5B gene
    Horiike, N
    Michitaka, K
    Masumoto, T
    Okura, I
    Akbar, SMF
    Onji, M
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1999, 14 (04) : 345 - 351
  • [22] Sequence diversity in the non-structural region 5A of hepatitis C virus and early response to peginterferon
    Jain, M
    Yuan, HJ
    Attar, N
    Reeck, A
    Carney, DS
    Gale, M
    Lee, WM
    HEPATOLOGY, 2005, 42 (04) : 565A - 565A
  • [23] The non-structural 5A protein of the hepatitis C virus blocks the anti-viral effects triggered by IFN-α
    Paterson, M
    Laxton, CD
    Sully, R
    Thomas, HC
    Ackrill, A
    Foster, GR
    HEPATOLOGY, 1998, 28 (04) : 370A - 370A
  • [24] CASEIN KINASE Iα PHOSPHORYLATES A KEY SITE IN NON-STRUCTURAL PROTEIN 5A RESPONSIBLE FOR HEPATITIS C VIRUS REPLICATION
    Chong, W. M.
    Kao, W. T.
    Hsu, S. C.
    Shao, J. S.
    Chen, Y. H.
    Yu, M. J.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S137 - S137
  • [25] Mutations in nonstructural protein 5A gene and response to interferon in hepatitis C virus genotype 2 infection
    Murakami, T
    Enomoto, N
    Kurosaki, M
    Izumi, N
    Marumo, F
    Sato, C
    HEPATOLOGY, 1999, 30 (04) : 1045 - 1053
  • [26] Inhibition of Intrahepatic Gamma Interferon Production by Hepatitis C Virus Nonstructural Protein 5A in Transgenic Mice
    Kanda, Tatsuo
    Steele, Robert
    Ray, Ranjit
    Ray, Ratna B.
    JOURNAL OF VIROLOGY, 2009, 83 (17) : 8463 - 8469
  • [27] Quasispecies analysis in non-structural 5A (NS5A) region of hepatitis C virus (HCV) genotype 1b in interferon (IFN) or combined interferon-ribavirin (IFN-R) therapy resistance
    Payan, C.
    Veillon, P.
    Le Guillou-Guillemette, H.
    Gaudy, C.
    Lunel, F.
    ANTIVIRAL THERAPY, 2007, 12 (05) : S40 - S40
  • [28] Quasispecies analysis in non-structural 5A (NS5A) region of hepatitis C virus (HCV) genotype 1b in interferon (IFN) or combined interferon-ribavirin (IFN-R) therapy resistance
    Payan, C.
    Veillon, P.
    Le Guillou-Guillemette, H.
    Gaudy, C.
    Lunel, F.
    ANTIVIRAL THERAPY, 2007, 12 : S40 - S40
  • [29] Non-structural 5a (NS5A) protein and HCV genotype 3a sensitivity to interferon (IFN)-alpha therapy
    Castera, L
    Leroux, M
    Soulier, A
    Brillet, R
    Lonjon, I
    Dhumeaux, D
    Pawlotsky, JM
    JOURNAL OF HEPATOLOGY, 2001, 34 : 117 - 117
  • [30] Evolution of hepatitis C virus non-structural 5A gene in the progression of liver disease to hepatocellular carcinoma
    De Mitri, Maria Stella
    Cassini, Romina
    Bagaglio, Sabrina
    Morsica, Giulia
    Andreone, Pietro
    Marino, Nicoletta
    Bernardi, Mauro
    LIVER INTERNATIONAL, 2007, 27 (08) : 1126 - 1133